[1] Maruyama K,Ochiai A,Akimoto S,et al.Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer.Oncology,2000,59:302-309. [2] Pham K,Milovanovic T,Barr R J,et al.Wnt ligand expression in malignant melanoma:pilot study indicating correlation with histopathological features.Mol Pathol,2003,56:280-285. [3] Reifenberger J,Knobbe CB,Wolter M,et al.Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1,APC,ICAT and BTRC.Int J Cancer,2002,100:549-556. [4] Demunter A,Libbrecht L,Degreef H,et al.Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.Mod Pathol,2002,15:454-461. [5] Maelandsmo GM,Holm R,Nesland JM,et al.Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.Clin Cancer Res,2003,9:3383-3388. [6] Omholt K,Platz A,Ringborg U,et al.Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma.Int J Cancer,2001,92:839-842. [7] Rubinfeld B,Robbins P,El-Gamil M,et al.Stabilization of betacatenin by genetic defects in melanoma cell lines.Science,1997,275:1790-1792. [8] Murakami T,Toda S,Fujimoto M,et al.Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells:role of LEF-1 in melanoma with increased metastatic potential.Biochem Biophys Res Commun,2001,288:8-15. |